FOR IMMEDIATE RELEASE:
PrimeraDx Announces the Expansion of its Senior Management Team
Mansfield, MA — March 22, 2010 — Daniel M. Bowman has joined PrimeraDx, Inc. as Vice President of Sales and Marketing.
In this position, he will be responsible for developing and executing the PrimeraDx commercialization plan for ICEPlex™, ViraQuant™ and future products.
"We are very pleased that Daniel Bowman has joined our team. He has over 20 years of experience in sales, marketing and management in the healthcare industry. He will develop and accelerate our commercialization efforts." commented Martin L Verhoef, CEO and President of PrimeraDx.
Dan was most recently employed as the Vice President of Global Commercial Operations for Osmetech Molecular Diagnostics where he was responsible for all aspects of commercial operations, culminating in the successful launch and commercialization of two FDA cleared systems. Prior to Osmetech Mr. Bowman has held various senior management, sales and marketing positions within Gentra Systems, Applied Imaging and Idexx Laboratories. Mr. Bowman began his career at Abbott Laboratories Diagnostic Division, and was a former Army Infantry Officer.
Mr. Bowman received his B.A. from California State University, Stanislaus and a M.A. from California State University, Chico.
PrimeraDx is dedicated to the emerging field of molecular diagnostics. The company is developing multiplexed, quantitative and cost effective assays using its proprietary STAR technology implemented on the ICEPlex instrument platform. STAR combines quantitative PCR with the ability to multiplex up to 60 targets in a single sample. The Company’s initial products are for infectious disease management. PrimeraDx plans to extend its focus into oncology to support cancer therapy management through diagnostic, prognostic, staging and therapeutic monitoring. The Company’s website is: http://www.primeradx.com.